+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 84 Actively Recruiting clinical trials

O

Actively Recruiting

Diffuse large B-cell lymphoma DLBCL is the most common and aggressive subtype of non-Hodgkin lymphoma NHL, affecting many patients with rapid tumor growth and symptoms depending on tumor location. This observational study aims to understand the clinical characteristics, treatment patterns, and access to new therapies for patients with DLBCL in the Middle East and Africa region, including both newly diagnosed and relapsed or refractory cases. Participants are grouped into two cohorts those who are newly diagnosed and eligible for treatment, and those who have relapsed or are refractory after at least one prior therapy. The study does not involve experimental treatments but collects information on how patients are treated in real-world settings and explores access to innovative therapies. During the study, patient demographics, disease characteristics, risk profiles, and treatment patterns are documented over 22 months. Researchers will gather data through reviews of medical records and clinical information without administering treatments. The primary goal is to describe first-line and subsequent treatment approaches and to understand patient access to novel therapies for DLBCL.

All AgesAll Genders
21 locations
L

Actively Recruiting

Researchers are evaluating etavopivat, a new oral medicine being developed for blood disorders such as sickle cell disease and thalassaemia. These inherited conditions affect hemoglobin, the protein responsible for carrying oxygen in the body. This long-term study aims to assess the safety and effectiveness of etavopivat treatment over a period of up to 264 weeks, or until the drug is approved in the participants country. Participants will receive one of several oral doses of etavopivat, with dosing adjusted by age those 12 years and older will receive Etavopivat A or C, while children younger than 12 years will receive Etavopivat B. The study involves multiple groups including adults, adolescents, and children with different types of sickle cell disease or thalassaemia. All participants have completed a prior etavopivat treatment study and are continuing treatment in this rollover study. During the study, participants will be regularly monitored for treatment-related side effects and clinical benefits. Researchers will track adverse events, blood crisis rates, hemoglobin levels, hospitalizations, and blood transfusion needs. The study includes long-term safety and efficacy assessments conducted over several years, with monitoring continuing until study completion or drug approval. Participants health and treatment responses will be carefully followed throughout this extended period.

Age: 2Years +All GendersPhase 3
107 locations
E

Actively Recruiting

Stage III periodontitis is a serious gum disease that damages the tissues supporting teeth. This trial evaluates whether adding an active oxygen-releasing gel, with or without photodynamic therapy, improves treatment results compared to standard care alone. Researchers aim to better control inflammation and harmful bacteria beyond what scaling and root planing SRP can achieve. The study involves three groups of 42 patients with stage III periodontitis. One group receives SRP plus the oxygen-releasing gel applied to the gums for three minutes. A second group receives SRP, the gel, and antimicrobial photodynamic therapy using a diode laser with a special dye to target bacteria. The third group receives SRP alone using ultrasonic and manual tools. Participants gum health will be monitored by measuring gingival index, bleeding on probing, pocket depth, and attachment levels at the start and after one and three months. Microbiological samples will be taken to measure specific bacterial levels related to periodontitis. The study includes random assignment to groups and single masking, with assessments to track changes in clinical and bacterial outcomes.

Age: 30Years - 70YearsAll GendersPhase Not Applicable
1 location
R

Actively Recruiting

Healthy Volunteer

This research aims to evaluate whether an AI-based psychiatric simulation program can reduce mental illness stigma and improve readiness for psychiatric nursing practice among fourth-year nursing students at Alexandria University. The trial will also investigate if students sense of psychological safety during simulation-based learning explains these effects. Two hundred students will be randomly assigned to either an intervention or control group. Participants in both groups will follow the standard psychiatric-mental health nursing curriculum, including theoretical instruction, clinical rotation, and usual simulation activities. The intervention group will additionally complete five weekly AI-simulation cases focused on different psychiatric conditions, each lasting 15 to 20 minutes. These cases include structured interviews with simulated patients, stigma-trigger statements, automated feedback, and opportunities to retry. Throughout the study, mental illness stigma, readiness for psychiatric practice, and psychological safety will be measured online at baseline and immediately after the fifth simulation case. Intervention participants will also answer open-ended questions to provide qualitative insights. The study involves online questionnaires and simulation sessions over five weeks, with no further long-term follow-up described.

Age: 18Years +All GendersPhase Not Applicable
1 location
E

Actively Recruiting

Researchers are evaluating the use of oscillometry and fractional exhaled nitric oxide FeNO testing in primary care to diagnose asthma and chronic obstructive pulmonary disease COPD. The study compares these methods to specialist-based diagnosis, aiming to address challenges with spirometry, such as patient effort, technical difficulties, and reproducibility, which affect diagnostic accuracy especially in primary care settings. This observational study is conducted across 7 countries in the Middle East, Africa, Asia, and Latin America at hospital sites, focusing on patients with suspected asthma or COPD. Primary care physicians are trained to use oscillometry and FeNO testing following international guidelines, using tools like the Ambulatory Lung Diagnosis System. Patients suspected of asthma or COPD undergo symptom questionnaires and primary care assessment with these tests. If specialist diagnosis cannot be done same day, it occurs within three days. There are no follow-up visits planned. The study aims to assess the technical feasibility and diagnostic accuracy of these tools in routine primary care compared to specialist diagnosis. Participants provide consent, complete history and symptom questionnaires, and undergo oscillometry and FeNO testing at primary care sites. Diagnostic accuracy is measured by comparing primary care results to specialist diagnoses using statistical metrics like Cohens kappa, sensitivity, and specificity within 1 to 3 days. No additional follow-up or long-term monitoring is planned. The studys findings will help determine if these methods can improve early and accurate diagnosis of asthma and COPD in primary care.

Age: 18Years +All Genders
12 locations
C

Actively Recruiting

Researchers are evaluating changes in the labial bone plate after immediate implant placement in Type II extraction sockets using two different xenograft materials along with a de-epithelialized free gingival graft in the esthetic zone. This randomized clinical trial aims to compare the effects of these grafting materials on bone preservation and implant success. The study addresses concerns about bone changes following tooth extraction and immediate implant placement, focusing on maintaining bone and soft tissue structure in the front upper jaw area. Participants will undergo immediate implant placement after tooth extraction in the esthetic zone. They will be randomly assigned to one of two groups receiving defect grafting with either Medpark S1 xenograft or bio-Oss xenograft. Both groups will also receive a de-epithelialized free gingival graft during the procedure. The interventions involve placing the implant and grafting material in the extraction socket to support bone and tissue preservation. During the study, clinical evaluations and standardized radiographic assessments using CBCT scans will be conducted to measure changes in labial bone plate thickness and peri-implant bone stability. Implant success will be monitored over a follow-up period of six months. Researchers will assess outcomes such as bone thickness changes and peri-implant mucosal levels, ensuring participants compliance and safety throughout the trial.

All AgesAll GendersPhase Not Applicable
1 location
C

Actively Recruiting

Researchers are evaluating two ways of delivering autologous nanofat grafts to treat post-burn and traumatic atrophic scars. The study compares injections of nanofat grafts with microneedling combined with nanofat grafts to see which method better improves scar appearance. This interventional trial is sponsored by Alexandria University and focuses on adults with scars lasting more than six months. Participants will have two scars with similar properties treated differently one scar or part of a large scar will receive nanofat graft injections, while the other scar or part will be treated with microneedling combined with nanofat grafts. Both treatments involve procedures using the patients own nanofat tissue. The study is non-randomized and does not use masking. During the study, researchers will assess changes in the scars using the Patient and Observer Scar Assessment Scale POSAS six months after treatment. Participants must be adults aged 18 to 60 years with scars older than six months and not currently receiving other scar treatments. The study excludes certain types of scars and participants with specific medical conditions. The total follow-up period for outcomes is six months after the procedures.

Age: 18Years - 60YearsAll GendersPhase Not Applicable
1 location
C

Actively Recruiting

This research aims to evaluate treatments for children aged 5 to 7 years who have deep cavities in their second primary molars that need vital pulp therapy. The study compares two materials, MTA and bioceramic putty, used for pulpotomy, followed by full coverage of the teeth with either stainless steel crowns or 3D printed resin crowns. The trial is a randomized controlled clinical study sponsored by Alexandria University. During treatment, caries will be removed from the affected molars reaching the pulp, and pulpotomy will be performed by controlling bleeding. The pulp chamber will be covered with either MTA or bioceramic putty. Resin-modified glass ionomer will then be placed, and the tooth will be prepared for a full crown. Participants will receive either stainless steel crowns or digitally designed 3D printed resin crowns created using advanced scanning and printing technology. Participants will be monitored at 1 week, 6 months, and 12 months after treatment to assess clinical and radiographic success of the pulpotomy. Crowns will be evaluated at 6 and 12 months using a standardized dental service scale. Both parental and child satisfaction regarding the appearance, color, size, durability, and overall outcome will be measured immediately and at follow-up visits. The study will track these outcomes throughout the planned observation period ending in 2027.

Age: 5Years - 7YearsAll GendersPhase Not Applicable
1 location
E

Actively Recruiting

Laparoscopic sleeve gastrectomy LSG is a common weight loss surgery that involves removing part of the stomach to create a smaller, narrow stomach sleeve. This procedure helps patients lose weight and improve related health problems. Researchers are studying the impact of different bougie sizes, which are tubes used to shape the stomach during surgery, to find the best balance between safety and weight loss outcomes. The study compares smaller bougies 36-Fr and larger bougies over 40-Fr in a randomized controlled trial. Participants will be randomly assigned to receive LSG with either a larger calibration bougie >40-Fr or a standard smaller bougie 36-Fr. The study devices are medical-grade, single-use calibration tubes. The trial will assess surgical outcomes including complications, weight loss, quality of life, food tolerance, pain levels, and hospital stay length. Follow-up will include upper gastrointestinal evaluations and nutritional assessments over one year. Participants will undergo detailed assessments before and after surgery, including questionnaires about quality of life and food tolerance, weight measurements, pain scoring, and monitoring for complications such as gastric leaks within three months. Nutritional labs and upper GI studies will be done at several points up to one year. The study aims to capture comprehensive data on safety, recovery, and long-term effects of bougie size on surgery outcomes.

Age: 18Years - 70YearsAll GendersPhase Not Applicable
1 location
C

Actively Recruiting

Researchers are evaluating the effect of two different hand rubbing methods, chlorhexidine gluconate and alcohol, on healthcare-associated infections HCAI in neonates admitted to the neonatal intensive care unit NICU at Alexandria University Childrens Hospital. The study focuses on newborns born before 37 weeks gestational age to understand how these hand hygiene practices impact infection rates during their hospital stay. In this randomized study, medical staff use either chlorhexidine gluconate or alcohol hand rubs before contacting the neonates during their NICU stay. The participants are assigned to one of these two groups to compare the impact of each hand rub method on infection prevention. The study specifically observes neonates admitted within 72 hours of birth and follows them during their hospital stay. Participants will be closely monitored with blood cultures taken during the first month of life to track infections. The study measures the rate of bloodstream infections as the primary outcome. Researchers will observe the neonates throughout their NICU stay until discharge. The total participation time varies depending on each neonates duration in the NICU and follow-up during the first month of life.

Age: 6Hours - 1DayAll GendersPhase Not Applicable
1 location

1-10 of 84

1